title: All-trans retinoic acid in acute promyelocytic leukemia in late pregnancy.
abstract: All-trans retinoic acid (ATRA) was used in a case of acute promyelocytic leukemia (APL) in late pregnancy. A very prompt maternal risk reduction was achieved with subsequent complete remission and spontaneous delivery of two live children in whom no fetal damage seems to have occurred.
authors.affiliation: Department of Medicine and Haematology, Aarhus University Hospital, Denmark.
authors.forename: J
authors.initials: J
authors.lastname: Stentoft
authors.forename: J L
authors.initials: JL
authors.lastname: Nielsen
authors.forename: L E
authors.initials: LE
authors.lastname: Hvidman
mesh_terms: D000328:Adult; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000097:blood / Q000188:drug therapy*; D007958:Leukocyte Count; D010976:Platelet Count; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000097:blood / Q000188:drug therapy*; D011256:Pregnancy Outcome; D011263:Pregnancy Trimester, Third; D012074:Remission Induction; D013918:Thrombin Time; D014212:Tretinoin / Q000627:therapeutic use*
chemical_list: D006454:Hemoglobins; D014212:Tretinoin; D005340:Fibrinogen